Kyoto, Japan

Mitsuhiro Machara

This inventor holds 2 USPTO granted patents. Top assignee: Nippon Shinyaku Company, Ltd.. Active years: 1978-1979.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Kyoto, JA (1978)
  • Kyoto, JP (1979)

Company Filing History:


Years Active: 1978-1979

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mitsuhiro Machara: Innovator in Carboxylic Acid Derivatives

Introduction

Mitsuhiro Machara is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of carboxylic acid derivatives. With a total of 2 patents, his work focuses on innovative solutions for health-related issues.

Latest Patents

Mitsuhiro Machara's latest patents include the development of substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives. These new carboxylic acid derivatives are proposed for use as agents in the treatment or prevention of arteriosclerosis. A typical compound in this category is 1-(p-chlorophenoxy)-3-(N-phenyl-N-carbomethoxymethylamino)-2-propanol. This innovative approach aims to address significant health challenges associated with arteriosclerosis.

Career Highlights

Mitsuhiro Machara is currently associated with Nippon Shinyaku Company, Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

Mitsuhiro collaborates with esteemed colleagues such as Hiroshi Enomoto and Katsuhide Saito. Their combined expertise contributes to the innovative research being conducted at Nippon Shinyaku Company, Ltd.

Conclusion

Mitsuhiro Machara stands out as an influential inventor in the field of medicinal chemistry. His contributions, particularly in the development of carboxylic acid derivatives, hold promise for improving health outcomes. His ongoing work continues to inspire advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…